首页 | 本学科首页   官方微博 | 高级检索  
检索        


Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian,fallopian tube,and primary peritoneal cancer patients
Authors:Iwasa-Inoue  Naomi  Nomura  Hiroyuki  Kataoka  Fumio  Chiyoda  Tatsuyuki  Yoshihama  Tomoko  Nanki  Yoshiko  Sakai  Kensuke  Kobayashi  Yusuke  Yamagami  Wataru  Morisada  Tohru  Hirasawa  Akira  Aoki  Daisuke
Institution:1.Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan
;2.Department of Obstetrics and Gynecology, National Hospital Organization Saitama Hospital, Saitama, Japan
;3.Department of Obstetrics and Gynecology, School of Medicine, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan
;4.Department of Obstetrics and Gynecology, International University of Health and Welfare School of Medicine, Chiba, Japan
;5.Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
;
Abstract:International Journal of Clinical Oncology - This study aimed to investigate the clinical benefit of dose-dense paclitaxel plus carboplatin (TC) with bevacizumab therapy for advanced ovarian,...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号